Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Andrews

Showing results (1221-1230 of 1,272) with videos related to

Pageof 128
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 21, 2022
Favipiravir for Treatment of Outpatients With Asymptomatic or Uncomplicated Coronavirus Disease 2019: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 TrialMarisa Holubar, Aruna Subramanian, Natasha Purington, et al.
Nature Communications|March 31, 2021
Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trialPrasanna Jagannathan, Jason R Andrews, Hector Bonilla, et al.
Psychosomatics|July 16, 2020
Updates in Consultation-Liaison Psychiatry: 2019Scott A Simpson, Lydia A Chwastiak, Sarah R Andrews, et al.
The Lancet. Infectious Diseases|April 3, 2022
Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control studyThiago Cerqueira-Silva, Jason R Andrews, Viviane S Boaventura, et al.
Scientific Reports|October 27, 2022
Gauging the skin resident Leishmania parasites through a loop mediated isothermal amplification (LAMP) assay in post-kala-azar dermal leishmaniasisPrakash Ghosh, Rajashree Chowdhury, Shomik Maruf, et al.
Cell Reports. Medicine|May 19, 2022
TNF-α<sup>+</sup> CD4<sup>+</sup> T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodiesKattria van der Ploeg, Adam S Kirosingh, Diego A M Mori, et al.
Nature Communications|October 6, 2022
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in BrazilOtavio T Ranzani, Matt D T Hitchings, Rosana Leite de Melo, et al.
Oncoimmunology|October 10, 2015
A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with <i>Candida</i> skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3William W Greenfield, Shawna L Stratton, Rebecca S Myrick, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Nextstrain automates real-time phylodynamic analysis of open data for endemic and emerging pathogensKimberly R Andrews, Jennifer Chang, Cornelius Roemer, et al.
Frontiers in Cardiovascular Medicine|March 29, 2021
Chronic Stress-Related Neural Activity Associates With Subclinical Cardiovascular Disease in a Community-Based Cohort: Data From the Washington, D.C. Cardiovascular Health and Needs AssessmentTiffany M Powell-Wiley, Amit K Dey, Joshua P Rivers, et al.
Pageof 128

Showing results (1221-1230 of 1,272) with videos related to

Sort By:
Pageof 128
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 21, 2022
Favipiravir for Treatment of Outpatients With Asymptomatic or Uncomplicated Coronavirus Disease 2019: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 TrialMarisa Holubar, Aruna Subramanian, Natasha Purington, et al.
Nature Communications|March 31, 2021
Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trialPrasanna Jagannathan, Jason R Andrews, Hector Bonilla, et al.
Psychosomatics|July 16, 2020
Updates in Consultation-Liaison Psychiatry: 2019Scott A Simpson, Lydia A Chwastiak, Sarah R Andrews, et al.
The Lancet. Infectious Diseases|April 3, 2022
Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control studyThiago Cerqueira-Silva, Jason R Andrews, Viviane S Boaventura, et al.
Scientific Reports|October 27, 2022
Gauging the skin resident Leishmania parasites through a loop mediated isothermal amplification (LAMP) assay in post-kala-azar dermal leishmaniasisPrakash Ghosh, Rajashree Chowdhury, Shomik Maruf, et al.
Cell Reports. Medicine|May 19, 2022
TNF-α<sup>+</sup> CD4<sup>+</sup> T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodiesKattria van der Ploeg, Adam S Kirosingh, Diego A M Mori, et al.
Nature Communications|October 6, 2022
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in BrazilOtavio T Ranzani, Matt D T Hitchings, Rosana Leite de Melo, et al.
Oncoimmunology|October 10, 2015
A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with <i>Candida</i> skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3William W Greenfield, Shawna L Stratton, Rebecca S Myrick, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Nextstrain automates real-time phylodynamic analysis of open data for endemic and emerging pathogensKimberly R Andrews, Jennifer Chang, Cornelius Roemer, et al.
Frontiers in Cardiovascular Medicine|March 29, 2021
Chronic Stress-Related Neural Activity Associates With Subclinical Cardiovascular Disease in a Community-Based Cohort: Data From the Washington, D.C. Cardiovascular Health and Needs AssessmentTiffany M Powell-Wiley, Amit K Dey, Joshua P Rivers, et al.
Pageof 128